The CONSIGN project will collect data on the impact of Covid-19 in pregnancy with the aim to guide decision-making about vaccination policies and treatment options for COVID-19 in pregnancy. The project is carried out in collaboration with ConcePTION, the COVI-PREG project, and the International Network of Obstetric Survey Systems (INOSS) network, with an open invitation for more researchers to join! The end goal is to create a sustainable global infrastructure that can be used for prospective monitoring of the benefits and risks of different treatments in pregnancy. Extending well beyond the current Covid-19 health crisis.
CONSIGN will analyse data from existing data sources like electronic health records and hospital data, together with information from cohorts of pregnant women. The aim is to provide information on the effect of Covid-19 infection and treatments in different trimesters of the pregnancy, and what effects it can have on neonates. If you want to know more about this project, please have a look at the CONSIGN-International document, where the Consortium describes ongoing initiatives and opportunities to collaborate. The invitation is open to all researchers!
CONSIGN was initiated by the European Medicines Agency, who has contracted Utrecht University and the University Medical Center Utrecht to coordinate. The project is being carried out in collaboration with the ConcePTION consortium, which was established under the EU’s Innovative Medicines Initiative, the COVI-PREG project, and the International Network of Obstetric Survey Systems (INOSS) network.
Want to collaborate? Please contact ConcePTION coordinator Professor Miriam Sturkenboom, UMC Utrecht. For more information, please have a look at: